Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Add shares to your
quickpicks to
display them here!

Fusion Antibody (FAB)

Price 6.25p on 22-09-2023 at 16:30:02
Change 1.35p 27.55%
Buy 6.50p
Sell 6.00p
Buy / Sell FAB Shares
Last Trade: Unknown 130,000.00 at 6.15p
Day's Volume: 3,383,052
Last Close: 6.25p
Open: 5.25p
Day's Range 5.00p - 6.25p
52wk Range: 4.90p - 61.00p
Market Capitalisation: £4m
VWAP: 5.767855p
Shares in Issue: 59m

Recent Trades History Fusion Antibody (FAB)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 130,000 6.15p Ordinary
15:25:51 - 22-Sep-23
Buy* 50,000 6.25p Ordinary
15:29:57 - 22-Sep-23
Buy* 10,000 6.24p Ordinary
15:28:48 - 22-Sep-23
Buy* 2,500 6.24p Ordinary
15:28:34 - 22-Sep-23
Buy* 4,000 6.195p Ordinary
15:27:51 - 22-Sep-23
Sell* 100,000 6.15p Ordinary
15:26:11 - 22-Sep-23
Sell* 100,000 6.15p Ordinary
15:26:09 - 22-Sep-23
Buy* 121 6.50p Ordinary
15:25:28 - 22-Sep-23
Buy* 85,000 6.69p Suspected BUY Trade
15:25:12 - 22-Sep-23
Buy* 400 6.375p Ordinary
15:12:56 - 22-Sep-23

Share Price History for Fusion Antibody

Time period:
Date Open High Low Close Volume

Share News for Fusion Antibody

IN BRIEF: Fusion Antibodies appoints part-time CFO on cash struggles

24th Aug 2023 12:10

Fusion Antibodies PLC - Belfast-based contract research organisation providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Appoints Stephen Smyth as interim chief financial officer with immediate effect. Smyth was previously CFO at Sera Global LP, and has held senior finance positions at Cormark Securities Inc and PricewaterhouseCoopers LLP. He is currently a partner at FPM Accountants Ltd. Read More

AIM WINNERS & LOSERS: Fulcrum Utility to leave AIM as loss widens

21st Aug 2023 10:29

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More

Fusion Antibodies inks deal with AI learning firm, hails lower costs

21st Aug 2023 09:35

(Alliance News) - Fusion Antibodies PLC on Monday said it signed an agreement with an unnamed artificial intelligence & machine learning company, which it said could cut costs per sequence test significantly. Read More

Fusion Antibodies completes "difficult" restructuring

14th Aug 2023 08:41

(Alliance News) - Fusion Antibodies PLC on Monday said it has completed its restructuring plans, in hopes of reducing annualised costs by about GBP2.2 million. Read More

UK shareholder meetings calendar - next 7 days

1st Jun 2023 15:52

Read More

FTSE 100 Latest

Login to your account

Forgot Password?

Not Registered